FDA, CDC rescind pause on J&J vaccine. Advisory panel voted 10-4 in favor.
▪ An advisory panel for the CDC on Friday recommended that the US resume administering the J&J Covid-19 vaccine.
▪ The FDA and CDC release says “The FDA has determined that the available data show that the vaccine’s known and potential benefits outweigh its known and potential risks in individuals 18 years of age and older.”
▪ On April 13, the FDA recommended a pause in the use of the J&J vaccine, citing cases of a rare blood clot disorder.
▪ The J&J statement says “We will continue to collaborate with the CDC, FDA and health authorities around the world, including the European Medicines Agency and WHO to ensure this very rare event can be identified early and treated effectively.”
Direct, authoritative source material on this story.
Articles Citable has ingested related to this story.
Percentage of day’s news
Citable analysis assessing the language of each article related to the story as positive, negative or neutral.
Publications covering this story along with their cumulative positive or negative sentiment.